Meet Our Clinical Advisory Board

Our clinical advisory board members bring decades of experience in dermatology, skin cancer, genomics, and biotech innovation to help us redefine the way we test and treat skin cancer.

Neal Bhatia, M.D.

Dr. Neal Bhatia is a board-certified dermatologist with extensive expertise and more than 20 years of experience in all facets of medical dermatology. Dr. Bhatia is former Vice President of the American Academy of Dermatology (AAD 2021) and former Secretary/Treasurer of the Noah Worcester Dermatological Society (2022). He sits on the Board of Directors for AAD.  Dr. Bhatia is Director of Clinical Dermatology at Therapeutics Clinical Research and has served as Principal Investigator for numerous dermatological studies. He has a background in immunology and has interests in mechanisms of therapy, skin cancer, and medical dermatology.

Laura Ferris, M.D., Ph.D.

Laura Korb Ferris, M.D., Ph.D., is a Professor and Director of Clinical Trials at the University of Pittsburgh Department of Dermatology. She is a member of the University of Pittsburgh Cancer Institute melanoma program, where she directs the pigmented lesions clinic. Dr. Ferris has been an investigator on several clinical trials evaluating technologies and assays for melanoma early detection and predictors of outcome in patients with melanoma. Her research, which is primarily focused on melanoma epidemiology, screening, and early detection has been widely published in the peer-reviewed literature. Dr. Ferris received her Ph.D. in immunology from The Johns Hopkins School of Medicine and her M.D. from The University of Maryland and she completed her residency in dermatology and fellowship in cutaneous oncology at the University of Pittsburgh.

Mark Kaufmann, M.D.

Mark Kaufmann, M.D., is a Clinical Professor in the Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York City and Immediate-Past President of the American Academy of Dermatology (AAD). In September 2020, Dr. Kaufman joined Advanced Dermatology and Cosmetic Surgery as their Chief Medical Officer. Dr. Kaufmann has served on the AAD Board of Directors as well as serving as Chair for other AAD committees. In addition, Dr. Kaufmann currently serves on the Board of Directors of the American Society for Dermatologic Surgery, the Florida Academy of Dermatology, and is an advisor to the AAD RUC team (Relative Value Scale Update Committee). Dr. Kaufmann’s contributions to the American Academy of Dermatology have been recognized by his receiving 6 Presidential Citations. With many articles published on the topic of health information technology, Dr. Kaufmann is a frequent national lecturer, including the AAD Annual Meeting, other national and regional societies, and grand rounds.

Lorraine Rosamilia, M.D.

Dr. Rosamilia is a board-certified dermatologist in State College, Pennsylvania, with clinical interests in melanoma, infectious disease, acne/rosacea, and psoriasis. She is a member of the Board of Directors and Scientific Committee of the Pennsylvania Academy of Dermatology and the American Medical Association delegation from Pennsylvania, chair of the Learning Resources Committee of the American Academy of Dermatology, and vice chair of the Board of Trustees of the Pennsylvania Medical Society. Dr. Rosamilia is also an Associate Editor of Cutis.

Daniel Siegel, M.D.

Dr. Daniel Siegel is a Clinical Professor of Dermatology and former Director of the Procedural Dermatology Fellowship at SUNY Downstate. He has served as president of the AAD (2012) and is a past member of both the Academy’s Board of Directors and Coding and Reimbursement Task Force. He is a diplomate of the American Board of Dermatology and the American Board of Laser Surgery and is a fellow of the American Society for Dermatologic Surgery (ASDS), the American Academy of Dermatology (AAD), the American College of Mohs Surgery and the American Society of Mohs Surgery.

Maral Skelsey, M.D.

Maral Kibarian Skelsey, M.D., is Director of the Dermatologic Surgery Center of Washington in Chevy Chase, MD. Dr. Skelsey has unique training in dermatology, pathology and reconstructive surgery and is double board certified in Dermatology and Mohs Dermatologic Surgery. Dr. Skelsey is Clinical Professor of Dermatology at Georgetown University Medical School and was founding director of the Mohs Surgery Unit and Multi-disciplinary Transplant Clinic as well as the former director of Dermatologic Surgery at the George Washington University. Her research is focused on gene expression profiling for melanoma and noninvasive detection modalities for skin cancer. Dr. Skelsey is a Diplomate of the American Academy of Dermatology (AAD) and is past president of the Washington DC Dermatologic Society, Fellow of the American Society of Laser Medicine and Surgery, the American College of Mohs Surgery and the American Society of Dermatologic Surgery.